RETRACTED: The pharmacodynamics and efficacy of Implanon® - An overview of the data (Retracted Article)

被引:124
作者
Croxatto, HB
Mäkäräinen, L
机构
[1] Inst Chileno Med Reprod, Consultorio Planificac Familiar, Dept 101, Santiago, Chile
[2] Univ Oulu, Dept Obstet & Gynecol, SF-90220 Oulu, Finland
关键词
implant; contraception; progestin-only; etonogestrel; pharmacodynamics; contraceptive efficacy; Implanon (R);
D O I
10.1016/S0010-7824(98)00118-8
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Implanon(R) is a long-acting reversible contraceptive method, consisting of a single rod that is applied subdermally. Ovulation inhibition was determined by serum progesterone (P) levels and ultrasound scanning (USS) of the ovaries. Ovarian function was further assessed by serum estradiol (E-2) levels. The effects of Implanon on serum gonadotropin levels (follicle-stimulating hormone [FSH] and luteinizing hormone [LH]) and on cervical mucus were also investigated, by means of Insler scores and sperm penetration tests. The effect on the endometrium was assessed by endometrial biopsies and USS. The Pearl index was calculated over 13 studies performed according to Good Clinical Practice (GCP), including 1716 women using Implanon. Return of ovulation after implant removal was determined by P levels and USS of the ovaries. The contraceptive efficacy of Implanon was high, with zero pregnancies during 53,530 cycles (4103 woman-years), resulting in a Pearl index of 0.0 (95% confidence interval, 0.00-0.09). This was achieved by inhibition of ovulation, which was reflected by suppressed P levels, as the primary mode of action. Ovulation was inhibited, but otherwise ovarian activity was still present (follicle growth, E-2 synthesis). The FSH serum concentrations were only slightly lower than preinsertion levels and LH surges were prevented. The viscosity of the cervical mucus was increased. The endometrium was thin but not atrophic; it showed primarily inactive or weak proliferation. Return of ovulation after removal of Implanon was rapid. (C) 1998 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:91S / 97S
页数:7
相关论文
共 10 条
[1]   RETRACTED: An integrated analysis of vaginal bleeding patterns in clinical trials of Implanon® (Retracted Article) [J].
Affandi, B .
CONTRACEPTION, 1998, 58 (06) :99S-107S
[2]  
Corfman Philip, 1995, Contraception, V52, P71, DOI 10.1016/S0010-7824(95)00143-3
[3]   CLINICAL-TRIAL WITH 3-KETO-DESOGESTREL SUBDERMAL IMPLANTS [J].
DIAZ, S ;
PAVEZ, M ;
MOOYOUNG, AJ ;
BARDIN, CW ;
CROXATTO, HB .
CONTRACEPTION, 1991, 44 (04) :393-408
[4]   HORMONAL EFFECTS OF THE 300 MU-G NORETHISTERONE (NET) MINIPILL .1. DAILY STEROID-LEVELS IN 43 SUBJECTS DURING A PRETREATMENT CYCLE AND DURING THE SECOND MONTH OF NET ADMINISTRATION [J].
LANDGREN, BM ;
DICZFALUSY, E .
CONTRACEPTION, 1980, 21 (01) :87-113
[5]   Ovarian function during the use of a single contraceptive implant:: Implanon compared with Norplant [J].
Mäkäräinen, L ;
van Beek, A ;
Tuomivaara, L ;
Asplund, B ;
Bennink, HC .
FERTILITY AND STERILITY, 1998, 69 (04) :714-721
[6]   PROGESTIN-ONLY ORAL CONTRACEPTION - A COMPREHENSIVE REVIEW [J].
MCCANN, MF ;
POTTER, LS .
CONTRACEPTION, 1994, 50 (06) :S9-S195
[7]   CLINICAL-RESULTS WITH SUBCUTANEOUS IMPLANTS CONTAINING 3-KETO DESOGESTREL [J].
OLSSON, SE ;
ODLIND, V ;
JOHANSSON, E .
CONTRACEPTION, 1990, 42 (01) :1-11
[8]   INTERNATIONAL EXPERIENCE WITH NORPLANT AND NORPLANT-2 CONTRACEPTIVES [J].
SIVIN, I .
STUDIES IN FAMILY PLANNING, 1988, 19 (02) :81-94
[9]   Clinical performance of a new two-rod levonorgestrel contraceptive implant: A three-year randomized study with Norplant(R) implants as controls [J].
Sivin, I ;
Viegas, O ;
Campodonico, I ;
Diaz, S ;
Pavez, M ;
Wan, L ;
Koetsawang, S ;
Kiriwat, O ;
Anant, MP ;
Holma, P ;
Abdalla, KE ;
Stern, J .
CONTRACEPTION, 1997, 55 (02) :73-80
[10]   CONTRACEPTION WITH NORPLANT(R) IMPLANTS [J].
SIVIN, I .
HUMAN REPRODUCTION, 1994, 9 (10) :1818-1826